These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 16517171

  • 1. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
    Van der Mey M, Windhorst AD, Klok RP, Herscheid JD, Kennis LE, Bischoff F, Bakker M, Langlois X, Heylen L, Jurzak M, Leysen JE.
    Bioorg Med Chem; 2006 Jul 01; 14(13):4526-34. PubMed ID: 16517171
    [Abstract] [Full Text] [Related]

  • 2. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
    Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A.
    J Pharmacol Exp Ther; 2002 Nov 01; 303(2):791-804. PubMed ID: 12388666
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ, Mannoury la Cour C, Chanrion B, Dupuis DS, Di Cara B, Audinot V, Cussac D, Newman-Tancredi A, Kamal M, Boutin JA, Jockers R, Marin P, Bockaert J, Muller O, Dekeyne A, Lavielle G.
    J Pharmacol Exp Ther; 2012 Mar 01; 340(3):750-64. PubMed ID: 22178752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C, Honer M, Salazar JF, Ross TL, Schubiger PA, Ametamey SM.
    Nucl Med Biol; 2009 Aug 01; 36(6):613-22. PubMed ID: 19647167
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.
    Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, Lejeune F, Rivet JM, Brocco M, Duqueyroix D, Nicolas JP, Boutin JA, Newman-Tancredi A.
    J Pharmacol Exp Ther; 2001 Jun 01; 297(3):876-87. PubMed ID: 11356907
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.
    Van der Mey M, Janssen CG, Janssens FE, Jurzak M, Langlois X, Sommen FM, Verreet B, Windhorst AD, Leysen JE, Herscheid JD.
    Bioorg Med Chem; 2005 Mar 01; 13(5):1579-86. PubMed ID: 15698775
    [Abstract] [Full Text] [Related]

  • 13. [Ethyl-3H]RS-79948-197 alpha2-adrenoceptor autoradiography validation in alpha2-adrenoceptor knockout mice.
    Fagerholm V, Philipp M, Hein L, Scheinin M.
    Eur J Pharmacol; 2004 Aug 30; 497(3):301-9. PubMed ID: 15336948
    [Abstract] [Full Text] [Related]

  • 14. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ, Dekeyne A, Newman-Tancredi A, Cussac D, Audinot V, Milligan G, Duqueyroix D, Girardon S, Mullot J, Boutin JA, Nicolas JP, Renouard-Try A, Lacoste JM, Cordi A.
    J Pharmacol Exp Ther; 2000 Dec 30; 295(3):1192-205. PubMed ID: 11082457
    [Abstract] [Full Text] [Related]

  • 15. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
    Airaksinen AJ, Jablonowski JA, van der Mey M, Barbier AJ, Klok RP, Verbeek J, Schuit R, Herscheid JD, Leysen JE, Carruthers NI, Lammertsma AA, Windhorst AD.
    Nucl Med Biol; 2006 Aug 30; 33(6):801-10. PubMed ID: 16934699
    [Abstract] [Full Text] [Related]

  • 16. Meperidine, remifentanil and tramadol but not sufentanil interact with alpha(2)-adrenoceptors in alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptor knock out mice brain.
    Höcker J, Weber B, Tonner PH, Scholz J, Brand PA, Ohnesorge H, Bein B.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):70-7. PubMed ID: 18234187
    [Abstract] [Full Text] [Related]

  • 17. In vivo evaluation in rodents of [(123)I]-3-I-CO as a potential SPECT tracer for the serotonin 5-HT(2A) receptor.
    Blanckaert PB, Burvenich I, Wyffels L, De Bruyne S, Moerman L, De Vos F.
    Nucl Med Biol; 2008 Nov 17; 35(8):861-7. PubMed ID: 19026947
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
    Balle T, Perregaard J, Ramirez MT, Larsen AK, Søby KK, Liljefors T, Andersen K.
    J Med Chem; 2003 Jan 16; 46(2):265-83. PubMed ID: 12519065
    [Abstract] [Full Text] [Related]

  • 20. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice.
    Höcker J, Böhm R, Meybohm P, Gruenewald M, Renner J, Ohnesorge H, Scholz J, Bein B.
    J Pharm Pharmacol; 2009 Jul 16; 61(7):901-10. PubMed ID: 19589232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.